Clinical Trial Update: The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluates the safety and effectiveness of a regimen combining Interleukin-2 with Zidovudine and Thymosin in HIV-infected individuals, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Thymosin (thymosin alpha-1)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED